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Abstract
The pineal gland is a small pinecone-shaped and functionally endocrine structure located in
the epithalamus region. Developmentally, the pineal gland is considered as a part of the
epithalamus. It plays a role in the entrainment of the circadian rhythms of an organism by
producing melatonin, a functionally important hormone. Lesions of the pineal region are rare
compared to other parts of the brain. A lesion may be tumorous or non-tumorous in nature. The
most common lesions are tumors that are pineal parenchymal tumors (PPT) in origin. Gliomas
are the second most common tumors in the pineal region. We report a case of a high-grade
oligodendroglioma, not commonly seen in the pineal region, in a 45-year-old male. The patient
was suspected to have a mass in the pineal region on a computed tomography (CT) scan and
histology confirmed the diagnosis of oligodendroglioma. This is a unique case because only five
such cases have been reported so far.

Categories: Internal Medicine, Medical Education, Neurology
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Introduction
The pineal gland is a small endocrine gland located in the epithalamus region. It produces
melatonin, which helps in modulating the sleep cycle. Malignancies of the pineal gland arising
from itself are very rare. The spectrum of tumors arising in this region is broad. Almost more
than 17 heterogeneous tumors can arise in this region.
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To our knowledge, only five cases of oligodendroglioma of the pineal region have been reported
in the literature. This is the sixth case, which makes this incidence a unique presentation.
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Case Presentation
A 45-year-old man presented to the outpatient department with complaints of a frontal
headache for the last four months. His pain was 6/10 on the intensity scale. The headache
usually occurred in the morning, was severe in intensity, was associated with dizziness, and
usually responded to over-the-counter pain medication. For past four months, the patient
reported visual disturbances in the form of blurry vision, but on thorough examination by the
ophthalmology department, a peripheral visual defect was ruled out and magnetic resonance
imaging (MRI) of the brain was advised.
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The patient underwent a brain MRI and was referred to the medicine outpatient department
where it was revealed that the patient had a mass in the pineal region as shown in Figure 1 and
the CT scan in Figure 2.

FIGURE 1: Tumor in the Pineal Region
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FIGURE 2: Pineal Region Mass on CT Scan
CT - computed tomography.

His baselines including the complete blood count, basic metabolic panel, liver function test,
urine detailed report and chest X-ray were within normal limits. The patient denied any family
history of brain tumors. His past medical history included diabetes and hypertension for the last
five years. Both were well controlled on losartan and Glucophage, respectively.
Neurological consult was sought and the patient was advised to get a brain biopsy done to
channel the diagnosis into effective treatment options. The sample was processed and sent for
histology. It showed a neoplastic lesion composed of polygonal cells against a fibrillary
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background. These neoplastic cells had a round nucleus exhibiting a moderate degree of
pleomorphism and surrounded by a perinuclear halo. Significantly increased mitotic activity
was appreciated. The immunohistochemical analysis came with positive CD 57, CD99, CD 10,
diffuse positive for GFAP (glial fibrillary acidic protein), weak positivity for synaptophysin, and
a high Ki-67 index (around 17 percent of cells). Cytokeratin and extractable nuclear antigen
(ENA) immunohistochemical stains were also negative. Fluorescent insitu hybridization (FISH)
performed on a small number of cells showed deletion of 1p and 19q.
In the light of all these findings, a diagnosis of oligodendroglioma was concluded. The patient
was offered radiation and chemotherapy options like procarbazine, methyl-1-(2-chloroethyl)1-nitrosourea (CCNU) and vincristine (also known as PCV therapy). After a detailed discussion,
the patient and his family declined both options. Surgical management was also proposed but
the patient deferred it.

Discussion
Oligodendrogliomas, a type of glioma, are believed to originate from the oligodendrocytes of
the brain or from a glial precursor cell. Overall, they constitute less than 20% of all intracranial
tumors and less than 25% of gliomas [1]. Their prevalence is mostly among adults during
midlife and rare in the pediatric population, occurring exclusively in the cerebral hemisphere
predominantly in the male population with a male to female ratio of 1.28:1 [1-3]. Most cases
have been reported in Caucasian, African American, and Hispanic populations. On diagnostic
imaging, these tumors are mostly found in the temporal lobe in the pediatric population, while
in adults they have been mostly reported in the frontal cortex region [1]. They occur at a
median age of 30 and the most common presenting symptoms are headache (78%), seizures
(43%), motor symptoms (38%), and to a lesser extent behavioral changes [4-5].The pathologic
grade of the tumor has been an essential element in determining the progression of symptoms
and survival rate. Patients with low grade or pediatric patients with good performance status at
initial presentation had a better survival rate following treatment [4, 6].
The pineal region is a complex anatomical site sheltering the pineal gland surrounded by the
quadrigeminal plate and the confluence of the internal cerebral veins forming the vein of Galen
[7]. Although germinal cell tumors and pineal cell tumors form the majority of the histological
tumors, more than 17 different tumors can arise in this location [8]. A pie chart distribution of
tumor and non-tumor lesions of the pineal gland by the histological sub type based on an
observational study of 12 years is shown in Figure 3 [2].

FIGURE 3: Pinealoma Subtypes on the Basis of Histology
The smaller pie chart contains three subtypes of pineal parenchymal tumors (PPT).
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Gliomas are a very rare subtype of pineal region tumors; oligodendrogliomas of the pineal
region, being a subtype of gliomas, further contribute to exclusively rare tumors with very few
reported cases reported till date [5, 9].
As stated previously, the grade of the tumor determines the course of the disease and
treatment, with the overall five-year progression-free survival rate being around 79% for lowgrade tumors as compared to 39% for high-grade tumors [3]. Pineal tumors and especially
germinal tumors are chemosensitive and radiosensitive; care of these tumors is
multidisciplinary involving surgery, chemotherapy, and radiotherapy [3-4, 9]. Our patient was
offered the treatment but he and his family members refused to agree to surgical resection or
any form of chemo and radiotherapy. However, they did agree to frequent follow-ups after
proper counseling as a part of palliative treatment.
To our knowledge, only five cases of oligodendroglioma of the pineal region have been reported
in the literature. This is the sixth case, which makes this incidence a unique presentation. The
findings of all previous five cases and the current case are compiled in Table 1. The details of
the five cases are mentioned after the literature review of the corresponding case [2, 10].

Age, Sex

Month,
Year of

Presenting Symptoms

Histological
Diagnosis

Treatment Given

reporting
30, Male

January,
2006

Not mentioned

Anaplastic OD

Not mentioned

35, Female

January,
2006

Not mentioned

Anaplastic OD

Not mentioned

59, Female

September,
2006

confusion + memory
disturbance

Anaplastic OD

Surgical resection + chemo- &
radiotherapy

Diplopia

Low-grade OD

Surgical resection

37, Female

September,
2010

Headache + intermittent

22, Female

February,
2015

Headache of increasing
severity for one month

Low-grade OD

Surgical resection

45, Male
(Current
Case)

July, 2017
(Current
Case)

Frontal headache + transient
visual obscuration (Current
Case)

High-grade
OD (Current
Case)

Chemo- & radiotherapy (Patient
denied surgical resection) (Current
Case)

TABLE 1: Cases of Oligodendroglioma in the Pineal Gland

Conclusions
We present this case of oligodendroglioma in the pineal gland as it is the sixth case reported till
now. This case will serve to remind physicians about its occurrence and presentation. A
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headache as the initial presentation of many illnesses should be given due consideration and
one should rule out every possible cause. This, in turn, would help us to design a management
layout for such an exceedingly rare tumor.

Additional Information
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